Cedazuridine and Decitabine

CHEBI:CHEBI_753694

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2384465
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20241231
route
ORAL
dosage_form
TABLET, FILM COATED
active_ingredient_strength
100 mg/100mg
pharm_class_moa
Nucleic Acid Synthesis Inhibitors [MoA]
pharm_class
Nucleoside Metabolic Inhibitor [EPC]
pharm_class_epc
Nucleoside Metabolic Inhibitor [EPC]
marketing_start_date
20240104
package_marketing_start_date
07-JUL-20
nui
N0000175595
labeler_name
Taiho Pharmaceutical Co., Ltd.
active_ingredient_name
CEDAZURIDINE
unii
39IS23Q1EW
generic_name
CEDAZURIDINE and DECITABINE
product_ndc
64842-0727
spl_id
10194470-7d36-4406-9372-55a2609d545e
package_ndc
64842-0727-9
package_description
1 BLISTER PACK in 1 CARTON (64842-0727-9) / 5 TABLET, FILM COATED in 1 BLISTER PACK
manufacturer_name
Taiho Pharmaceutical Co., Ltd.
brand_name
INQOVI
brand_name_base
INQOVI
application_number
NDA212576
spl_set_id
91a0f80b-f865-4d06-a40d-4d148d99ee71
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class